At Touch, we are committed to tackling the most pressing health challenges in the communities we serve. Of these health challenges, non-communicable diseases (NCDs), such as cancer, diabetes, and cardiovascular diseases, pose a significant risk to the wellbeing of millions. In fact, 77% of all NCD deaths occur in low- and middle-income countries and in sub-Saharan Africa they are poised to overtake infectious diseases as major sources of mortality by 2030.
In light of these trends, Touch is partnering with Sanofi’s Global Health Unit to improve patient outcomes for those living with NCDs in Tanzania. Our new program, MediFIKIA (fikia meaning “reach” in Swahili) strengthens supply chains, improves the operations of hospital pharmacies, and ultimately ensures that rural patients can access medicines for NCDs when they need them most.
Building upon previous programs to improve diagnosis and treatment of rheumatic heart disease and high blood pressure (hypertension), this project furthers our vision of creating strong, resilient, well-resourced hospitals, and cements our long-term commitment to improving NCD care outcomes for vulnerable patients.
We are so excited to join Sanofi in developing this new program!